Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 21,001-21,012 of 23,847
Drug study icon
CompletedNCT06605599

ABBV-932 to Assess Adverse Events and Change for Bipolarity

This study is completed in the United States and in Japan. It is testing ABBV-932 to Assess Adverse Events and Change for Bipolarity.

Multiple locations, including Dothan
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Japan
Sponsor
AbbVie
Condition
Bipolarity
Drug study icon
CompletedNCT00056472

Pharmacotherapy of Psychotic Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Worcester
Depression, SchizophreniaDrugOver 18 Years
Countries
United States, Canada
Sponsor
Weill Medical College of Cornell University
Condition
Depression, Schizophrenia
Drug study icon
TerminatedNCT00686699

Preladenant for schizophrenia

This study was terminated. It is testing preladenant for schizophrenia.

Location not clearly listed
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
TerminatedNCT00772785

Probuphine in people with Opioid Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In North Miami
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Titan Pharmaceuticals
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.